MedPath

Problem Solving Therapy for Prostate Cancer Spousal Caregivers

Not Applicable
Completed
Conditions
Prostate Cancer
Registration Number
NCT02085096
Lead Sponsor
University of California, San Diego
Brief Summary

Problem-solving therapy programs have been shown to be effective among parents of children diagnosed with cancer. Efforts have been made to apply this same strategy to spouses/significant others of men diagnosed with prostate cancer. The purpose of this study is to test the efficacy of problem-solving therapy on the spouses of prostate cancer patients.

Detailed Description

Problem-solving therapy programs have been shown to be effective among parents of children diagnosed with cancer. Efforts have been made to apply this same strategy to spouses/significant others of men diagnosed with prostate cancer. The purpose of this study is to test the efficacy of problem-solving therapy on the spouses of prostate cancer patients.

Participants were randomly assigned to an experimental group which received problem-solving therapy, or to a control group which relied on their standard methods of coping (e.g. their normal therapist, family and friends).

Participants completed baseline surveys regarding their distress and coping prior to randomization. They then completed these surveys again at post-intervention (approximately 2-3 months post-baseline) and 6 months post-baseline to determine lasting effects of the intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
338
Inclusion Criteria
  • Diagnosed with prostate cancer within 18 months of study enrollment.
  • The patient and significant other cohabited
  • Couples resided in San Diego County
  • Both patient and significant other were sufficiently proficient in English
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Change from Baseline of Effects of Stress and Coping to Follow-upsFrom baseline to follow-ups at post-intervention (2-3 months post-baseline) and 6-months post-baseline
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UC San Diego Moores Cancer Center

πŸ‡ΊπŸ‡Έ

La Jolla, California, United States

UC San Diego Moores Cancer Center
πŸ‡ΊπŸ‡ΈLa Jolla, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.